ID: ALA2315307

Max Phase: Preclinical

Molecular Formula: C11H12N2O2S3

Molecular Weight: 300.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(C)SSc1nc2ccc([N+](=O)[O-])cc2s1

Standard InChI:  InChI=1S/C11H12N2O2S3/c1-3-7(2)17-18-11-12-9-5-4-8(13(14)15)6-10(9)16-11/h4-7H,3H2,1-2H3

Standard InChI Key:  RKHCOPMGGWGSHK-UHFFFAOYSA-N

Associated Targets(Human)

Thioredoxin 111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 300.43Molecular Weight (Monoisotopic): 300.0061AlogP: 4.74#Rotatable Bonds: 5
Polar Surface Area: 56.03Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.97CX LogD: 4.97
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.45Np Likeness Score: -1.67

References

1. DiRaimondo TR, Plugis NM, Jin X, Khosla C..  (2013)  Selective inhibition of extracellular thioredoxin by asymmetric disulfides.,  56  (3): [PMID:23327656] [10.1021/jm301775s]

Source